SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 59 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,000 | -91.1% | 13,486 | -90.7% | 0.00% | – |
| Q1 2016 | $79,000 | -43.2% | 145,557 | -6.0% | 0.00% | – |
| Q4 2015 | $139,000 | +15.8% | 154,773 | +4.5% | 0.00% | – |
| Q3 2015 | $120,000 | -73.8% | 148,091 | -2.6% | 0.00% | – |
| Q2 2015 | $458,000 | -87.3% | 152,003 | -89.7% | 0.00% | -100.0% |
| Q1 2015 | $3,611,000 | +2.6% | 1,473,843 | +6.8% | 0.00% | 0.0% |
| Q4 2014 | $3,518,000 | -58.5% | 1,379,779 | +16.2% | 0.00% | -50.0% |
| Q3 2014 | $8,479,000 | +8.4% | 1,187,555 | -1.0% | 0.00% | 0.0% |
| Q2 2014 | $7,820,000 | +14.4% | 1,199,361 | +15.9% | 0.00% | 0.0% |
| Q1 2014 | $6,838,000 | +65.3% | 1,034,564 | +18.5% | 0.00% | +100.0% |
| Q4 2013 | $4,137,000 | -8.6% | 872,732 | -4.3% | 0.00% | -50.0% |
| Q3 2013 | $4,524,000 | +8.2% | 912,178 | +13.1% | 0.00% | 0.0% |
| Q2 2013 | $4,182,000 | – | 806,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,869,261 | $32,186,000 | 2.31% |
| GREAT POINT PARTNERS LLC | 193,567 | $1,279,000 | 0.67% |
| Visium Asset Management, LP | 4,526,750 | $29,922,000 | 0.48% |
| Healthcare Value Capital, LLC | 103,185 | $682,000 | 0.45% |
| ALYDAR PARTNERS LLC | 550,565 | $3,639,000 | 0.36% |
| Rhenman & Partners Asset Management AB | 147,403 | $974,000 | 0.29% |
| HealthCor Management, L.P. | 690,000 | $4,561,000 | 0.27% |
| Sivik Global Healthcare LLC | 63,087 | $417,000 | 0.26% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,379,278 | $9,117,000 | 0.22% |
| Healthcare Value Capital, LLC | 50,000 | $331,000 | 0.22% |